Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1652
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18538262 | ALTERED CYTIDINE DEAMINASES AND METHODS OF USE | Non-Final OA | ILLUMINA, INC. |
| 18065644 | FABRIC AND HOME CARE COMPOSITION INCLUDING A PROTEASE | Final Rejection | The Procter & Gamble Company |
| 17841161 | CLEANING COMPOSITIONS COMPRISING POLYPEPTIDES HAVING ALPHA AMYLASE ACTIVITY | Final Rejection | The Procter & Gamble Company |
| 18288490 | NOVEL PROTEIN HAVING METHANE OXIDATION ACTIVITY | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 16954032 | CAS12A SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED RNA BASE EDITING | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18740839 | Method For Improving Mitochondrial Functions | Final Rejection | TOHOKU UNIVERSITY |
| 18538539 | REVERSE TRANSCRIPTASE VARIANTS FOR IMPROVED PERFORMANCE | Non-Final OA | 10X GENOMICS, INC. |
| 18384537 | FUSION RT VARIANTS FOR IMPROVED PERFORMANCE | Non-Final OA | 10x Genomics, Inc. |
| 18591697 | USE OF TYPE III POLYKETIDE SYNTHASES FROM BACTERIA AS PHLOROGLUCINOL SYNTHASES | Final Rejection | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN |
| 18251505 | SPLIT PRIME EDITING PLATFORMS | Non-Final OA | The Board of Trustees of the University of Illinois |
| 18356052 | Polynucleotide Error Recognition Methods and Compositions | Non-Final OA | New England Biolabs, Inc. |
| 18005306 | IMPROVED PROCESS FOR SYNTHESIZING FUNCTIONALIZED MERCAPTANS | Final Rejection | ARKEMA FRANCE |
| 18596176 | MODIFIED ENZYMES | Non-Final OA | Oxford Nanopore Technologies PLC |
| 18650856 | ENGINEERED POLYMERASES WITH REDUCED SEQUENCE-SPECIFIC ERRORS | Non-Final OA | Element Biosciences, Inc. |
| 17904994 | Method for synthesizing a fluorine-containing chiral amine compound | Non-Final OA | ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. |
| 18389518 | Subtilase Variants and Compositions Comprising Same | Non-Final OA | Novozymes A/S |
| 18547525 | DNASE VARIANTS | Non-Final OA | Novozymes A/S |
| 18043515 | POLYESTER DEGRADING PROTEASE VARIANTS | Non-Final OA | Novozymes A/S |
| 18017704 | Modified Terminal Deoxynucleotidyl Transferase (TdT) Enzymes | Final Rejection | Nuclera Ltd |
| 18005467 | URACIL STABILIZING PROTEINS AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE | Final Rejection | LIFEEDIT THERAPEUTICS, INC. |
| 17295253 | NOVEL KETOSE 3-EPIMERASE | Non-Final OA | NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY |
| 18037937 | MAMMALIAN MOBILE ELEMENT COMPOSITIONS, SYSTEMS AND THERAPEUTIC APPLICATIONS | Non-Final OA | Blue Marlin Therapeutics, Inc.. |
| 18250989 | RECOMBINANT HOST CELLS TO PRODUCE ANTHRANILIC ACID | Non-Final OA | PILI |
| 18043179 | IDEONELLA SAKAIENSIS PET-HYDROLASE VARIANT WITH INCREASED THERMOSTABILITY | Non-Final OA | CycleZyme AB |
| 17208286 | DNA POLYMERASE MUTANTS HAVING ENHANCED TEMPLATE DISCRIMINATION ACTIVITY | Non-Final OA | Integrated DNA Technologies, Inc. |
| 17912770 | ATP-DEPENDENT DNA LIGASE | Final Rejection | ARCTICZYMES AS |
| 17416885 | MICROBIAL STRAINS ENGINEERED FOR IMPROVED FRUCTOSE UTILIZATION | Final Rejection | PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy